Ming Hsieh's SEC Form 4 Filing for Fulgent Genetics, Inc.

Ming Hsieh, Chief Executive Officer and a ten percent owner of Fulgent Genetics, Inc., filed a Form 4 with the SEC on August 5, 2025, reporting transactions on August 1, 2025. The filing details the withholding of 1,339 shares to satisfy tax obligations arising from the vesting of restricted stock units granted on August 1, 2022. Hsieh's ownership includes shares held in trusts and Uniform Transfers to Minor Act accounts, with a total of 7,895,115 shares held by the Dynasty Trust, 220,816 shares by the Hsieh Trust, and 2,000 shares in minor accounts. Following the transaction, Hsieh directly owns 809,340 shares. The filing highlights Hsieh's significant ownership and control over these shares.